AR126648A1 - Métodos para hacer un modulador de hemoglobina - Google Patents
Métodos para hacer un modulador de hemoglobinaInfo
- Publication number
- AR126648A1 AR126648A1 ARP220101300A ARP220101300A AR126648A1 AR 126648 A1 AR126648 A1 AR 126648A1 AR P220101300 A ARP220101300 A AR P220101300A AR P220101300 A ARP220101300 A AR P220101300A AR 126648 A1 AR126648 A1 AR 126648A1
- Authority
- AR
- Argentina
- Prior art keywords
- making
- methods
- hemoglobin
- modulator
- hemoglobin modulator
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La presente descripción se refiere a procesos para preparar un compuesto de fórmula (1) la descripción también proporciona compuestos que son intermediarios sintéticos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163188735P | 2021-05-14 | 2021-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR126648A1 true AR126648A1 (es) | 2023-11-01 |
Family
ID=82016260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220101300A AR126648A1 (es) | 2021-05-14 | 2022-05-13 | Métodos para hacer un modulador de hemoglobina |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11939323B2 (es) |
| EP (1) | EP4337658A1 (es) |
| JP (1) | JP2024520896A (es) |
| CN (1) | CN117677616A (es) |
| AR (1) | AR126648A1 (es) |
| AU (1) | AU2022273544B2 (es) |
| CA (1) | CA3219784A1 (es) |
| IL (1) | IL307906A (es) |
| MX (1) | MX2023013179A (es) |
| TW (1) | TW202311255A (es) |
| WO (1) | WO2022241286A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112023021606A2 (pt) * | 2021-05-14 | 2023-12-19 | Global Blood Therapeutics Inc | Formas sólidas de modulador de hemoglobina |
| WO2025262596A1 (en) * | 2024-06-20 | 2025-12-26 | Pfizer Inc. | Methods of making osivelotor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5543523A (en) | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
| US9248199B2 (en) | 2014-01-29 | 2016-02-02 | Global Blood Therapeutics, Inc. | 1:1 adducts of sickle hemoglobin |
| CN113316568B (zh) * | 2018-11-19 | 2024-11-08 | 全球血液疗法股份有限公司 | 能够调节血红蛋白的2-甲酰基-3-羟基苯基氧基甲基化合物 |
| US12492180B2 (en) | 2018-12-21 | 2025-12-09 | Curia Spain, S.A.U. | Process and intermediates for the preparation of Voxelotor |
-
2022
- 2022-05-13 IL IL307906A patent/IL307906A/en unknown
- 2022-05-13 MX MX2023013179A patent/MX2023013179A/es unknown
- 2022-05-13 TW TW111118077A patent/TW202311255A/zh unknown
- 2022-05-13 CA CA3219784A patent/CA3219784A1/en active Pending
- 2022-05-13 WO PCT/US2022/029304 patent/WO2022241286A1/en not_active Ceased
- 2022-05-13 AR ARP220101300A patent/AR126648A1/es not_active Application Discontinuation
- 2022-05-13 US US17/744,525 patent/US11939323B2/en active Active
- 2022-05-13 JP JP2023569773A patent/JP2024520896A/ja active Pending
- 2022-05-13 CN CN202280049084.0A patent/CN117677616A/zh active Pending
- 2022-05-13 AU AU2022273544A patent/AU2022273544B2/en not_active Expired - Fee Related
- 2022-05-13 EP EP22729361.0A patent/EP4337658A1/en active Pending
-
2024
- 2024-02-23 US US18/585,711 patent/US20250002484A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250002484A1 (en) | 2025-01-02 |
| US20220388996A1 (en) | 2022-12-08 |
| IL307906A (en) | 2023-12-01 |
| MX2023013179A (es) | 2023-12-01 |
| EP4337658A1 (en) | 2024-03-20 |
| US11939323B2 (en) | 2024-03-26 |
| AU2022273544A1 (en) | 2023-11-09 |
| TW202311255A (zh) | 2023-03-16 |
| JP2024520896A (ja) | 2024-05-27 |
| CA3219784A1 (en) | 2022-11-17 |
| CN117677616A (zh) | 2024-03-08 |
| WO2022241286A1 (en) | 2022-11-17 |
| AU2022273544B2 (en) | 2024-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022005121A (es) | Herbicida y método de producción para el intermediario del mismo. | |
| BR112022009390A2 (pt) | Síntese melhorada de composto inibidor de kras g12c | |
| AR126648A1 (es) | Métodos para hacer un modulador de hemoglobina | |
| CL2021001869A1 (es) | Complejo de gadolinio y un ligando quelatante derivado de pcta diastereoisoméricamente enriquecido y método de síntesis. | |
| CL2024002461A1 (es) | Síntesis de compuestos de quinazolina | |
| UY39789A (es) | Intermedio novedoso para la preparación de piroxasulfona. | |
| CO2021000940A2 (es) | Procedimiento y productos intermedios para la preparación de bilastina | |
| AR132848A1 (es) | Agonistas espiromacrocíclicos de receptores de orexina 2 | |
| MX2018014130A (es) | Procedimiento e intermedios para la 6,7-alfa-epoxidacion de 4,6-dienos esteroideos. | |
| MX2021007511A (es) | Procedimiento para la preparacion de anilinas sustituidas. | |
| CO2021001857A2 (es) | Preparación de intermedio útil para la síntesis de inhibidor de sglt | |
| UY39026A (es) | Proceso químico para la síntesis de compuestos de piridazina sustituida | |
| BR112021026061A2 (pt) | Método para o tratamento de uma composição que compreende vanilina natural | |
| CL2025000591A1 (es) | Métodos de tratamiento de la enfermedad de graves mediante anticuerpos anti-fcrn | |
| CO2023012775A2 (es) | Proceso químico | |
| UY39380A (es) | Proceso químico para la síntesis de compuestos de piridazina sustituidos | |
| AR110198A1 (es) | Síntesis de un compuesto que modula la actividad de proteínas que contienen bromodominio | |
| BR112023003328A2 (pt) | Preparação de composto acrilato substituído | |
| BR112023026276A2 (pt) | Preparação sintética para fumarato de diroximel | |
| CL2025001209A1 (es) | Proceso para la síntesis de compuestos de benzaldehído sustituidos con metoxi. | |
| MX2021006499A (es) | Proceso de preparacion de un enol eter biciclico. | |
| MX2022014838A (es) | Métodos para sintetizar farnesil dibenzodiazepinonas. | |
| AR133793A1 (es) | Proceso para la preparación de aminas alifáticas enantioméricamente enriquecidas | |
| AR133212A1 (es) | Proceso químico | |
| UY39381A (es) | Proceso químico para la síntesis de compuestos de piridazina sustituidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |